P000368

Should 21-hydroxylase deficiency genotyping be considered in assisted reproductive technology programs?

Fertility and sterility · 2007 · 10.1016/j.fertnstert.2007.01.030

Courtesy of the U.S. National Library of Medicine. This snapshot may differ from current PubMed records. NLM does not endorse this site.

Topic
21-hydroxylase deficiency (21OHD); Congenital adrenal hyperplasia (CAH)
Gene
CYP21A2

Citar este recurso

DSD Research Library | Should 21-hydroxylase deficiency genotyping be considered in assisted reproductive technology programs? | v1.4.0 | 2026-11-17 | https://dsdatlas.com/es/papers/P000368?version=v1.4.0